Emilia Javorsky
speaker
1,653 appearances
2 recordings
1 series
first heard Mar 2026
last heard 20 Mar
Emilia Javorsky’s voice in public audio — every appearance, attributed to the second.
Trend
recordings per month · last 12 monthsRecordings per month over the last 12 months — 2 in all, peaking in Mar 2026 with 2.
Appearances
Trials for late-stage disease are smaller and faster because advanced-stage patients experience clinical outcomes.
In this case, progression or death more quickly, allowing companies to reach their endpoints and complete trials with less time and expense.
Prevention trials, by contrast, must follow healthy people for years or decades, waiting for disease to occur, making them prohibitively expensive and slow.
The data we've just discussed analyzing Phase III trials expose why pharmaceutical development gravitates toward treating sick patients in their final months rather than preventing disease in the first place.
Fundamentally, the more individualized a disease and the earlier you seek to intervene, the more difficult diagnostic and therapeutic development becomes.
Myth of the Eureka Moment Discovery is not impact.
Silicon Valley often misses the bigger picture in therapeutic development by placing an erroneous equal sign between novel insight and clinical impact.
The Eureka myth refers to the narrative that invention derives from a moment of brilliant insight, as Sir Harold Evans wrote in the Harvard Business Review in 2005,
we romanticize the epiphany of total clarity, creating neat origin stories that obscure the messy reality of innovation.
Eureka, Greek for I have found it, remains the motto of Silicon Valley's home state of California, which fittingly appropriates a moment of scientific discovery to commemorate the gold rush.
Like the great founder narrative, the eureka myth spotlights a lone genius and packages innovation into a single divine moment.
This romanticism resonates particularly strongly in tech, where founding a software company can genuinely occur through such moments.
a brilliant mind, a laptop, and venture capital ready to invest in scalable solutions.
But therapeutic development bears little resemblance to software engineering.
Discovery is not the end point, but the beginning of what most closely resembles Homer's Odyssey, a decade-long journey tossed at sea.
facing insurmountable challenges, gatekeepers, and beating improbable odds to arrive at just the right moment.
Drug development requires precise intervention in the human body, a highly complex, chaotic, cooperative ecosystem, all while avoiding unintended consequences.
Success requires coordinated advances in clinical data generation,
Evan's noted that while we obsess over the invention moment,
The act of inventing and improving is far more often a long, hard slog, and the act of capitalizing on invention and of managing the transition from a brainwave to the bustle of the marketplace is the really hard part.
Showing 941–960 of 1,653 · page 48 of 83
← Previous
Next →